Adverse Drug Reactions With Fatal Outcome
NCT02838212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1135
Last updated 2016-07-20
Summary
The purpose of this study is to determine the incidence of drug-related deaths in a university hospital during the year 2015
Conditions
- Adverse Drug Reaction
Interventions
- DRUG
-
adverse drug reaction
drug-related death
Sponsors & Collaborators
-
Germans Trias i Pujol Hospital
lead OTHER
Principal Investigators
-
Eva Montané, PhD · Department of Clinical Pharmacology. Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2016-06-30
- Completion
- 2016-07-31
More Related Trials
-
Knowledge and Practices of ADR Reporting in LMICs
NCT04301219 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
NCT04960124 ·Status: COMPLETED ·Phase: PHASE1
-
Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium
NCT05535309 ·Status: COMPLETED
-
Rechallenge, Potential Drug Induced Liver Injury (Kaiser)
NCT01584765 ·Status: COMPLETED
-
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects
NCT00968422 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.
NCT00432627 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
NCT02154022 ·Status: ENROLLING_BY_INVITATION
-
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
NCT07231029 ·Status: RECRUITING ·Phase: PHASE1
-
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
NCT03093818 ·Status: COMPLETED ·Phase: NA
-
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
NCT04635111 ·Status: RECRUITING
-
A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
NCT02182167 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
NCT02170571 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
NCT01422135 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
NCT01704001 ·Status: COMPLETED ·Phase: PHASE4
-
Reduction of Adverse Drug Events and Readmissions
NCT02738047 ·Status: RECRUITING
-
A Retrospective Study on Drug Induced Liver Injury in China
NCT02407964 ·Status: COMPLETED
-
Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People
NCT02431832 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 mg Nicotinic Acid as Tablets in Healthy Subjects
NCT01258491 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers
NCT00619931 ·Status: COMPLETED ·Phase: PHASE1
-
A PK and Safety Study in Subjects With Hepatic Impairment
NCT01431833 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacodynamic Study of CD-NP
NCT00482937 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-841 Pharmacokinetic/Pharmacodynamic Study
NCT03233932 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
NCT02099071 ·Status: COMPLETED ·Phase: PHASE1
-
Adrecizumab-LPS Study
NCT03083171 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)
NCT02961413 ·Status: RECRUITING